Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  17080 of 17156  at  9/23/2020 7:10:53 AM  by

Biotech_Jim


 In response to msg 17079 by  good_investor93
view thread

Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD

 <Hopefully AXGT works out for you. There was a lot of enthusiasm three years ago about the drug it bought from Glaxo for Alzheimer's (interpidine) along with would-be pimavanserin competitor nelotanserin. Both drugs flopped in the clinic. AXGT's stock fell 70%, and the company ended up doing an 1-for-8 reverse split.>
 
And thus the opportunity.
 
AXGT is a totally different company today, and David Hung is no longer there. Current CEO seems really sharp in the gene therapy arena, and they did a nice deal with Oxford Biomedica. 
 
 I followed the nelotanserin debacle, and thought that the ACAD drug was better. I have a lot of confidence in the ACAD, and in Esq. Davis. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 321
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
17081 Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD BelieverTim 5 9/23/2020 9:50:47 AM






Financial Market Data provided by
.
Loading...